During the past decade, Japan Blood Products Organization conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Japan Blood Products Organization" are "End Stage Renal Disease" (1 trials) and "Recurrent Miscarriage" (1 trials). Many other conditions were trialed in "Japan Blood Products Organization" in a lesser frequency.

Most popular intervention types in "Japan Blood Products Organization" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "GB-0998" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Japan Blood Products Organization" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Japan Blood Products Organization". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Japan Blood Products Organization, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Japan Blood Products Organization, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".